Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary CNS Lymphoma”

400 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 400 results

Testing effectiveness (Phase 2)Looking for participantsNCT06940791
What this trial is testing

Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104)

Who this might be right for
Primary Central Nervous System Lymphoma
Kyorin University 92
Not applicableLooking for participantsNCT07188077
What this trial is testing

Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)Diffuse Large B-Cell Lymphoma
Ting YANG 20
Not applicableActive Not RecruitingNCT06024694
What this trial is testing

Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

Who this might be right for
Primary Mediastinal Large B-cell Lymphoma (PMBCL)
IRCCS San Raffaele 45
Not applicableStudy completedNCT03536975
What this trial is testing

Identify the Benefits CAREGIVERSPRO-MMD Platform Use Based on the Information and Communications Technology, Dedicated to the Support and Assistance of Dyads Living With Neurocognitive Diseases and Their Primary Caregivers

Who this might be right for
Cognitive Impairment, MildDementia, Mild
University Hospital, Rouen 48
Not applicableStudy completedNCT00004875
What this trial is testing

Heparin or Enoxaparin in Patients With Cancer

Who this might be right for
LymphomaThromboembolismUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT03038672
What this trial is testing

Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas

Who this might be right for
ALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+32 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT00066599
What this trial is testing

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Who this might be right for
Kidney CancerLeukemiaLymphoma+6 more
National Cancer Institute (NCI)
Not applicableUnknownNCT05347511
What this trial is testing

Study of the Pronostic Impact of Immunohistochemical, Histological and Radiological Factors in Patients With Primary Central Nervous System Lymphoma.

Who this might be right for
Rare Disease With Poor Outcome
Central Hospital, Nancy, France 94
Not applicableStudy completedNCT00594815
What this trial is testing

Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 52
Large-scale testing (Phase 3)Active Not RecruitingNCT04931368
What this trial is testing

OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Klinikum Stuttgart 331
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03210714
What this trial is testing

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Childhood Malignant Germ Cell Tumor+29 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT01325194
What this trial is testing

CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis

Who this might be right for
Primary Disease
Nordic Lymphoma Group 143
Testing effectiveness (Phase 2)Looking for participantsNCT04961515
What this trial is testing

Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Hodgkin Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 19
Large-scale testing (Phase 3)UnknownNCT02313389
What this trial is testing

Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Assistance Publique - Hôpitaux de Paris 428
Testing effectiveness (Phase 2)UnknownNCT00989352
What this trial is testing

Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma

Who this might be right for
Primary Non Hodgkin Lymphoma of the Central Nervous System
University Hospital Freiburg 56
Testing effectiveness (Phase 2)Ended earlyNCT06561425
What this trial is testing

A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Non-Hodgkin LymphomaLymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell
Lakefront Biotherapeutics NV 130
Not applicableUnknownNCT00757614
What this trial is testing

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsEsophageal Cancer+6 more
Cancer Research UK 14,000
Testing effectiveness (Phase 2)Looking for participantsNCT07014943
What this trial is testing

High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)
Sichuan University 34
Next Page